Mirabegron 223673-61-8 Inhibitor Neuronal tohu
Utu:T/T, L/C
Takenga Hua:Haina
Tauranga Tukunga:Beijing/Shanghai/Hangzhou
Te kaha whakaputa:100kg/marama
Raupapa(MOQ):25kg
Wā Arataki:3 Nga Ra Mahi
Tikanga rokiroki:Whakaorangia ki te waahi makariri, maroke, te pāmahana rūma.
rauemi mōkihi:pahū
Rahi mōkihi:25kg/pahū
Nga korero haumaru:Ehara i nga taonga kino
Kupu Whakataki
Mirabegron, he beta-3 adrenergic receptor agonist, e whakaihiihi ana i te beta-3 adrenergic receptor me te whakangawari i te uaua maeneene o te detrusor, na reira ka piki ake te kaha o te ngongo ka whakamahia ki te rongoa i nga tohu o te ngongo ngongo nui (OAB), penei i te tohe, te tere, me te auau.
Ko ona painga he rite ki te rongoa antimuscarinic penei i te solifenacin, tolterodine ranei.
Whakatakotoranga (USP/EP)
| Tūemi | Whakatakotoranga |
| Te ahua | Ma ki te paura ma |
| Tautuhinga | IR, HPLC |
| Te ihirangi wai | NMT 0.5% |
| Te toenga i runga i te mura | NMT 0.1% |
| Te whakarewa taumaha | NMT 20ppm |
| ihirangi Palladium | NMT 20ppm |
| Ihioma whatu | NTM 0.5% |
| Matū whai pānga | Z-168*: NMT 0.15% |
| SC03610*: NMT 0.15% | |
| Tetahi atu poke kore mohiotia: NMT 0.10% | |
| Tapeke poke: NMT 0.5% | |
| 2-(2-aminothianzol-4-yl) waikawa ahetiki | NMT 0.1% |
| Te toenga whakarewa | Mewaro: NMT 0.3% |
| Ethyl acetate: NMT 0.5% | |
| THF: NMT 0.072% | |
| Benzene: NMT 0.0002% | |
| Toluene: NMT 0.089% | |
| Te whakamatautau | 98.0% - 102.0% |
| PSD | D (0.5): 10μm - 30μm |
| D (0.9): 20μm - 80μm |
